The Ability of Lipoprotein (a) Level to Predict Early Carotid Atherosclerosis Is Impaired in Patients With Advanced Liver Fibrosis Related to Metabolic-Associated Fatty Liver Disease

INTRODUCTION: Hepatic fibrosis reduces the serum level of lipoprotein (a) (Lp(a)) and may affect its accuracy in cardiovascular disease prediction of metabolic-associated fatty liver disease (MAFLD). We aimed to estimate the association between Lp(a) levels and the risk of carotid atherosclerosis in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Tingfeng, Ye, Junzhao, Shao, Congxiang, Lin, Yansong, Wang, Wei, Feng, Shiting, Zhong, Bihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476839/
https://www.ncbi.nlm.nih.gov/pubmed/35608296
http://dx.doi.org/10.14309/ctg.0000000000000504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476839/
https://www.ncbi.nlm.nih.gov/pubmed/35608296
http://dx.doi.org/10.14309/ctg.0000000000000504

Ejemplares similares